NAMSA
Minneapolis, MN, United Statesnamsa.comFrom their website, Nov 2026
- GLP
- AAALAC
Work here? Claim this listing
About
NAMSA is a medical device contract research organization serving medical device and IVD manufacturers. It provides consulting, preclinical research, clinical research, and testing services for sponsors in North America, Europe, Asia, and Japan. The company focuses on medical device safety, effectiveness, and regulatory compliance.
Services
Consulting & Strategy
Provides regulatory strategy, compliance support, post-market support, reimbursement support, and market research for medical devices and IVDs.
US FDA & CMS Consulting
Supports FDA regulatory strategy and compliance, including 510(k), De Novo, IDE, PMA, breakthrough designation, QMSR audits, and reimbursement-related work.
EU MDR & IVDR Consulting
Supports EU MDR and IVDR compliance, including clinical/performance evaluation, technical documentation, PMS, PMCF, PMPF, PSUR, and CE marking documentation.
Global QA/RA Compliance
Provides global regulatory and quality consulting, including QA/RA outsourcing, ISO 13485 implementation, FDA mock audits, MDSAP, risk management, and regulatory remediation.
Human Factors & Usability Testing
Conducts usability and human factors research across early design, prototype, formative, and summative testing stages.
Medical Device GLP Studies
Conducts GLP-compliant preclinical studies for medical devices in its facilities in the United States and Europe.
ADME, DMPK & toxicology
Early Feasibility Studies
Supports early feasibility work for medical devices as part of preclinical research.
ADME, DMPK & toxicology
Preclinical Pathology
Provides pathology support for preclinical medical device studies.
ADME, DMPK & toxicology
11 more services
- Bioskills Training
- Preclinical Imaging Core Lab
- Clinical Trial Management
- Data Management
- Clinical Biostatistics
- Safety Management and Reporting
- Biocompatibility Testing
- Microbiology Testing
- Sterility Testing
- Chemical Characterization
- Biological Evaluation Plans
Capabilities
- Assays and studies
- Biocompatibility testing
- Microbiology testing
- Sterility testing
- Chemical characterization
- Biological evaluation
- Scale and capacity
- 21 fully equipped ORs, cath labs, and CT in US and Europe
- 4 labs in US and Europe
- 1,400+ professionals
- 157,000+ tests conducted last year
- 320 medical device or IVD clinical projects each year
- 3,000 medical device and IVD manufacturers supported each year
- 277 GLP preclinical studies in last 12 months
- 100K+ panel of HCP and administrator participants in global database
- Therapeutic areas
- Cardiovascular
- Dental
- Diabetes care
- Gastroenterology
- General surgery
- Neurovascular
4 more
- Ophthalmology
- Orthopedics
- Peripheral vascular
- Wound care
Instruments and platforms
- Fixed C-arm platforms
- Digital catheterization labs
Modalities and species
- Modalities
- Medical device
- In vitro diagnostic
- Software as a medical device
- Combination drug-device products
- Species and models
- Medical devices
- IVDs
- Animal tissue
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO/IEC 17025Self-reported
ISO 13485Self-reported
Scope: quality management systems
AAALACSelf-reported
Scope: preclinical facilities
GLPSelf-reported
Scope: preclinical studies
Company
- Type
- CRO
- Founded
- 1967
- Team
- 1,400+ professionals worldwide
Locations
- Based in
- Minneapolis, MN, United States
- Sites
- Northwood, United States · Toledo, United States
- Serves
- North America, Europe, Asia, United States, Japan, worldwide
- FDA GLP site
- Namsa, Minneapolis, US source
Public records
- GLP
- Inspected under GLP · FDA source